Nicole Sweeny

Insider Reports History

Location
C/O Praxis Precision Medicines, Inc., One Broadway, 16 Th Floor, Cambridge, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicole Sweeny:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Praxis Precision Medicines, Inc. Chief Commercial Officer Common Stock 38.6K $973K $25.19 Feb 12, 2023 Direct
KalVista Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 32.3K $433K $13.42 Aug 25, 2025 Direct
Praxis Precision Medicines, Inc. Chief Commercial Officer Stock Option (Right to Buy) 120K Jan 12, 2023 Direct
KalVista Pharmaceuticals, Inc. Chief Commercial Officer Restricted Stock Unit 55K Aug 22, 2025 Direct

Insider Reports Filed by Nicole Sweeny

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Aug 22, 2025 3 -$19.9K 4 Aug 26, 2025 Chief Commercial Officer
KALV KalVista Pharmaceuticals, Inc. Aug 21, 2025 3 -$24.6K 4 Aug 25, 2025 Chief Commercial Officer
KALV KalVista Pharmaceuticals, Inc. Jun 18, 2025 0 $0 3 Aug 25, 2025 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Feb 12, 2023 1 -$5.74K 4 Feb 13, 2023 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Jan 12, 2023 1 $0 4 Jan 17, 2023 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Jan 12, 2023 1 $0 4 Jan 13, 2023 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Jan 7, 2023 1 -$5.24K 4 Jan 9, 2023 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. May 13, 2022 1 $22.8K 4 May 18, 2022 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Feb 12, 2022 1 -$15.8K 4 Feb 15, 2022 Chief Commercial Officer
PRAX Praxis Precision Medicines, Inc. Jan 7, 2022 2 $0 4 Jan 11, 2022 Chief Commercial Officer